KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查 入排置信度 0.98

Plasma pTau217 ratio predicts continuous regional brain tau accumulation in amyloid-positive early Alzheimer's disease.

Viswanath Devanarayan, Arnaud Charil, Kanta Horie, Thomas Doherty, Daniel A Llano, Erica Andreozzi, Pallavi Sachdev, Yuanqing Ye, Leema Krishna Murali, Jin Zhou, Larisa Reyderman, Harald Hampel, Lynn D Kramer, Shobha Dhadda, Michael C Irizarry, Alzheimer's Disease Neuroimaging Initiative (ADNI)

Alzheimers Dement 21(2) e14411

PMID39575854
PMCIDPMC11848419
DOI10.1002/alz.14411
发表日期2024-11-22
入排依据:未发现恶性肿瘤人群证据。
摘要

摘要

BACKGROUND: This study examines whether phosphorylated plasma Tau217 ratio (pTau217R) can predict tau accumulation in different brain regions, as measured by positron emission tomography (PET) standardized uptake value ratio (SUVR), for staging Alzheimer's disease (AD). METHODS: Plasma pTau217R was measured using immunoprecipitation-mass spectrometry. Models for predicting tau PET SUVR, developed with 144 early AD individuals using [18F]MK6240, were validated in two validation sets, VS1 (98 early AD) and VS2 (47 preclinical/early AD with a different tracer, flortaucipir (Tauvid)), all amyloid-beta positive (Aβ+). RESULTS: The pTau217R-based model predicted tau levels up to an SUVR of 2 in multiple brain regions, effectively assessing tau status at different tau levels with receiver operating characteristic (ROC) curve areas of 0.84-0.95 in VS1 and 0.71-0.88 in VS2 (using a different tracer). It reduced PET scan needs by 65% while maintaining 95% sensitivity. DISCUSSION: PTau217R reliably predicts regional tau accumulation in early AD, reducing reliance on tau PET scans and broadening its clinical application. CLINICAL TRIAL REGISTRATION NUMBER: NCT03887455 (ClarityAD) HIGHLIGHTS: Developed a model using plasma pTau217R to predict tau levels across brain regions. pTau217R model outperformed models based on clinical, MRI, and other blood biomarkers. The model reliably predicted tau levels exceeding tau positivity and higher thresholds. Screening with pTau217R could reduce tau PET scans by 65% at 95% sensitivity. pTau217R model aids in disease staging and monitoring in early AD.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。